Kappa Opioid Receptors in the Pathology and Treatment of Major Depressive Disorder | SpringerLink
Opioid Receptors - Pharmacology
Antagonist for the Kappa Opioid Receptor - Probe Reports from the NIH Molecular Libraries Program - NCBI Bookshelf
A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics - ScienceDirect
Fluorine-18-Labeled Antagonist for PET Imaging of Kappa Opioid Receptors | ACS Chemical Neuroscience
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
PDF) Kappa opioid receptor antagonism: Are opioids the answer for treatment resistant depression?
Dynorphin, stress, and depression | Semantic Scholar
Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment - ScienceDirect
Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy | ACS Chemical Neuroscience
Advances in Sulfonamide Kappa Opioid Receptor Antagonists: Structural Refinement and Evaluation of CNS Clearance | ACS Chemical Neuroscience
Project 1: Therapeutic Potential of Kappa Opioid Receptor Antagonists in the Treatment of Depression (Chavkin) | Conte Center
In major depression, increased kappa and mu opioid receptor levels are associated with immune activation | Acta Neuropsychiatrica | Cambridge Core